We are live on ! Find out more
SRTAW

Strata Critical Medical Inc Warrants

Delisted

SRTAW was delisted on the 6th of May, 2026.

11 hedge funds and large institutions have $1.03M invested in Strata Critical Medical Inc Warrants in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more capital invested

Capital invested by funds: $661K → $1.03M (+$366K)

0% more funds holding

Funds holding: 1111 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.82% less ownership

Funds ownership: 8.53%7.7% (-0.82%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
11
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
2
Calls
$14K
Puts
Net Calls
+$14K
Net Calls Change
-$105K
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Capital
1
Walleye Capital
New York
$364K -$257 -1,000 -0%
Goldman Sachs
2
Goldman Sachs
New York
$284K -$159K -620,477 -27%
LP
3
LMR Partners
United Kingdom
$174K
Morgan Stanley
4
Morgan Stanley
New York
$118K
SA
5
Sanctuary Advisors
Indiana
$62.5K +$61.3K +238,588 New
WAM
6
Wolverine Asset Management
Illinois
$10.1K +$9.35K +36,412 +155%
Two Sigma Investments
7
Two Sigma Investments
New York
$6.3K
SCM
8
Saba Capital Management
New York
$6.22K
IC
9
IEQ Capital
California
$1.69K +$2.57K +10,000 New
TPCW
10
TD Private Client Wealth
New York
$101
TRCT
11
Tower Research Capital (TRC)
New York
$4
CAC
12
Cowen and Company
New York
-$4.96K -47,500 Closed
UBS Group
13
UBS Group
Switzerland
-$6 -54 Closed

SRTAW Hedge Fund Activity: Q2 2024 in Review

11 of the 6,928 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q2 2024, worth a combined $1.03M — up 55% from $661K a quarter earlier.

Fund positioning in SRTAW was balanced in Q2 2024: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Wolverine Asset Management, adding an estimated $9.35K. The largest seller was Goldman Sachs, cutting an estimated $159K.

  • 11 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $1.03M of Strata Critical Medical Inc Warrants stock for Q2 2024, up 55% quarter-over-quarter.
  • 2 funds opened new Strata Critical Medical Inc Warrants positions in Q2 2024 and 2 closed out, a net change of 0 holders.
  • The largest Strata Critical Medical Inc Warrants buyer in Q2 2024 was Wolverine Asset Management, an estimated $9.35K added.
  • The largest Strata Critical Medical Inc Warrants seller in Q2 2024 was Goldman Sachs, an estimated $159K sold.

Based on aggregated 13F filings for Q2 2024.